Welcome to Drug and Alcohol Treatment
| ||
Drug Treatment Neuropathy Article
This is a selection made from among articles on Drug Treatment Neuropathy. For a permanent link to this article, or to bookmark it for future reading, click here.
Illegal and Legal Drug Usage in the United States
from:by Lance Winslow
How bad is the illegal drug problem here in the US? Very bad and it alters the brain’s thought process and causes a problem with human interaction and our natural socializing tendencies. The drugs are so diverse and so plentiful that it touches the lives of nearly every American in some way and certainly nearly every family in this country. We must be honest with ourselves. We have legal drugs, prescription drugs and illegal drugs. Caffeine is a drug that is wide spread in America. The verdict is out now, but what will we learn in the future after twenty years? After all there is a Starbucks on nearly every corner in many of America’s largest metropolitan areas. We already know that spiders cannot spin a web while under influence of caffeine.What is Caffeine content in your life? Ask for yourself, look in that mirror and then take a look at the world around you. No wonder people cut you off in traffic, they are in a mad tear to where? In front of you so they can hurry up and wait. Now it appears that kids are using caffeine to get high? In combination with other drugs; think about this. The “pick me up” that most Americans use to get through the day, wake up in the mourning is penetrating other parts of society. Why? Why would this happen? Well here are some interesting stories of kids using caffeine to get a rush.http://www.twilightbridge.com/deaddictions/coffee.htmhttp://www.ecureme.com/emyhealth/natural/n_caffeine.asp .There is much more on Blogs across the Internet, “google” it sometime and see what you come up with. We have kids taking crystal meth and killing their bodies and becoming very horrible workers as far a responsibility and work ethic go, and when they cannot keep a job and have no money to buy drugs they are trying to duplicate some sort of experience using caffeine. Wow, this is a problem really. Think of all the mood altering drugs being used Prozac one-way, caffeine the other, and all the illegal stuff in between. How is the human brain suppose to operate efficiently and develop normally with all this foreign content and the extreme ratios? Maybe some people ought to figure out a way to reduce this desire for mood enhancement?There is much information on the Internet about this and perhaps we, as a society should be doing something to help people think about what they are doing to themselves? And to find a reason to live life to it’s fullest without a mood enhancements.http://healthcenter.ucdavis.edu/htcaffeine.htmlSo if we are to have caffeine as a way of life we ought to let people know that the caffeine buzz that kids are trying to get from using it is not all that great.http://www.ceida.net.au/tools_for_workers/...s/caffeine.htmlNow this maybe a better stimulate over all to other drugs, but no drugs is the better solution. It would be better for the productivity of America, better for kids and better for long-term health. Think about it.
Drug Treatment Neuropathy Specific links
Drug Treatment Neuropathy News
New study finds treatment for neuropathic pain - allvoices
New study finds treatment for neuropathic pain allvoices "Now we are working toward the possibility of potential treatments that might eliminate the source of neuropathic pain, and that may be much more effective than drugs that aim only to treat symptomatically the pain that results from chronic, ... Stem Cell Transplants Treat Chronic Pain |
Parents hire own researchers to tackle rare, fatal disease - Waterloo Record
 Kuwait Times | Parents hire own researchers to tackle rare, fatal disease Waterloo Record Warrior Mothers Gelse Tkalec (left) has a playful moment with her son Ethan before he begins aqua therapy in Burr Ridge, Illinois, earlier this month. Ethan suffers from a rare but serious illness called Giant Axonal Neuropathy. Rare disease finds no interested companies – Parents hire own researchers to ... |
Cell therapy may ease chronic pain - Pakistan Observer
Cell therapy may ease chronic pain Pakistan Observer “Now we are working toward the possibility of potential treatments that might eliminate the source of neuropathic pain, and that may be much more effective than drugs that aim only to treat symptomatically the pain that results from chronic, ... |
FDA Panel Grants Tafamidis Conditional Approval for Amyloidosis Neuropathy - Family Practice News Digital Network
 Updated News | FDA Panel Grants Tafamidis Conditional Approval for Amyloidosis Neuropathy Family Practice News Digital Network A single study of the investigational drug tafamidis provided enough evidence of its effectiveness as a treatment for polyneuropathy in patients with a rare form of hereditary amyloidosis to meet Food and Drug Administration criteria for an accelerated ... FDA Advisory Committee Finds Data Support Effectiveness of Tafamidis Meglumine ... |
Pfizer's Lyrica Fails In Inadequately Treated PDPN; Trial For New Use Halted - NASDAQ
 Fox11online.com | Pfizer's Lyrica Fails In Inadequately Treated PDPN; Trial For New Use Halted NASDAQ (RTTNews.com) - Pfizer Inc. (PFE) said Friday a late stage study of its neuropathic pain drug Lyrica failed to meet its primary point in patients with inadequately treated painful diabetic peripheral neuropathy, or pDPN - a form of nerve damage mainly ... Pfizer Reports Top-Line Results From Phase 3 Trial Of Lyrica (pregabalin ... Pfizer's Lyrica Nerve-Pain Drug Fails To Meet Endpoint In Diabetes Study Pfizer Axes Late-Stage Lyrica Study Following Disappointing Results |
Diamyd Medical's Phase II study in cancer pain fully recruited - MarketWatch (press release)
Diamyd Medical's Phase II study in cancer pain fully recruited MarketWatch (press release) The NTDDS platform comprises three drug candidates for the treatment of various forms of chronic pain; NP2 Enkephalin, NG2 GAD, NE2 Endomorphin and one drug candidate for the prevention of chemotherapy induced peripheral neuropathy, NN1 Neurotrophin. |
Pfizer halts late-stage study into possible additional use for pain treatment ... - Washington Post
 EON: Enhanced Online News (press release) | Pfizer halts late-stage study into possible additional use for pain treatment ... Washington Post NEW YORK — Pfizer halted a late-stage study of its second-best selling drug, Lyrica, as a possible treatment for a nerve pain in HIV patients. The world's largest drugmaker said Friday it was studying the drug in patients with HIV neuropathy, ... Pfizer Drug Lyrica Fails in Phase 3 Study In Patients With Diabetic Peripheral ... Pregabalin Fails to Improve Diabetic, HIV Neuropathy Lyrica Fails in Pain Trials |
NeuroMetrix Engages IRG for Investor Relations - MarketWatch (press release)
NeuroMetrix Engages IRG for Investor Relations MarketWatch (press release) The company currently markets NC-stat(R) DPNCheck(TM), a fast, accurate and quantitative point-of-care test for systemic neuropathies including DPN. It recently filed with the Food and Drug Administration a 510(k) premarket notification for the next ... |
DARA BioSciences Paves Foundation for Growth - Equities.com
DARA BioSciences Paves Foundation for Growth Equities.com In its pipeline, DARA is also in Phase 2 development of KRN5500, a treatment of neuropathic pain for patients with cancer. The drug candidate has received the Fast Track Designation by the Food and Drug Administration, and a recent external data ... |
Parents hire own researchers to tackle rare, fatal disease - Lexington Herald Leader
Parents hire own researchers to tackle rare, fatal disease Lexington Herald Leader His lab was hired by parents of GAN patients to use his specialized research to unlock a molecular understanding of the disease and hopefully, a drug therapy. Moreover, progress in studying GAN may offer new insights into more common neurological ... |